Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4XAT
|
||||
| Drug Name |
benzyl (S)-1-((S)-1-cyano-2-(4-(trifluoromethyl)phenyl)ethylamino)-4-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL380620
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H26F3N3O3
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc2ccc(cc2)C(F)(F)F)C#N
|
||||
| InChI |
InChI=1S/C24H26F3N3O3/c1-16(2)12-21(30-23(32)33-15-18-6-4-3-5-7-18)22(31)29-20(14-28)13-17-8-10-19(11-9-17)24(25,26)27/h3-11,16,20-21H,12-13,15H2,1-2H3,(H,29,31)(H,30,32)/t20-,21-/m0/s1
|
||||
| InChIKey |
NACLTILEMHZADB-SFTDATJTSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.